645 related articles for article (PubMed ID: 27794131)
21. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of ultrasonography in the diagnosis of central clearing of papillary thyroid carcinoma].
Zhao Z; Zhao Z; Ma J; Jing S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 29(6):538-41. PubMed ID: 26211162
[TBL] [Abstract][Full Text] [Related]
23. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
24. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma.
Wang QC; Cheng W; Wen X; Li JB; Jing H; Nie CL
Asian Pac J Cancer Prev; 2014; 15(2):855-60. PubMed ID: 24568507
[TBL] [Abstract][Full Text] [Related]
25. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
27. Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study.
Lai X; Zhang B; Jiang Y; Li J; Zhao R; Yang X; Zhang X; Zhu S; Wu Q; Cai S; Zhang Y
PLoS One; 2016; 11(2):e0148567. PubMed ID: 26881783
[TBL] [Abstract][Full Text] [Related]
28. Tumor border pattern and size help predict lymph node status in papillary microcarcinoma: A clinicopathologic study.
Taşkın OÇ; Armutlu A; Ağcaoğlu O; Peker Ö; Terzioğlu T; Demirkol MO; Tezelman S; Kapran Y
Ann Diagn Pathol; 2020 Oct; 48():151592. PubMed ID: 32871504
[TBL] [Abstract][Full Text] [Related]
29. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
30. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.
Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y
Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755
[TBL] [Abstract][Full Text] [Related]
31. Using Ultrasonography to Evaluate the Relationship between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiao WP; Zhang L
Chin Med J (Engl); 2017 Jun; 130(11):1309-1313. PubMed ID: 28524830
[TBL] [Abstract][Full Text] [Related]
32. [Study on the relationship between ultrasonographic features of papillary thyroid carcinoma and central cervical lymph node metastasis].
Wang XQ; Wei W; Wei X; Xu Y; Wang HL; Xing XJ; Zhang S
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):196-200. PubMed ID: 29575838
[No Abstract] [Full Text] [Related]
33. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases.
Hong YR; Yan CX; Mo GQ; Luo ZY; Zhang Y; Wang Y; Huang PT
Sci Rep; 2015 Jan; 5():7748. PubMed ID: 25582862
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
35. Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarcinoma.
Chung SR; Choi YJ; Lee SS; Kim SO; Lee SA; Jeon MJ; Kim WG; Lee JH; Baek JH
Thyroid; 2021 Mar; 31(3):452-458. PubMed ID: 33287640
[No Abstract] [Full Text] [Related]
36. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
37. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
Wang Y; Guan Q; Xiang J
Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.
Kim SY; Lee E; Nam SJ; Kim EK; Moon HJ; Yoon JH; Han KH; Kwak JY
PLoS One; 2017; 12(4):e0176103. PubMed ID: 28419171
[TBL] [Abstract][Full Text] [Related]
39. Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis.
Gülben K; Berberoğlu U; Celen O; Mersin HH
Langenbecks Arch Surg; 2008 Jan; 393(1):25-9. PubMed ID: 17690905
[TBL] [Abstract][Full Text] [Related]
40. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.
Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2004 May; 28(5):498-501. PubMed ID: 15085396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
